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Pet serine protease from enteroaggregative
Escherichia coli stimulates the inflammatory
response activating human macrophages
L. M. Rocha-Ramírez1*, U. Hernández-Chiñas2,3, D. Baños-Rojas1, J. Xicohtencatl-Cortés4, M. E. Chávez-Berrocal2,3,
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Abstract
Background: Pet is a toxin from the family of Serine Protease Autotransporters of Enterobacteriaceae which was
initially identified in Enteroaggregative Escherichia coli strains. This protease exhibits enterotoxin properties,
damages the cell cytoskeleton and induces intestinal epithelium alterations, which are associated with a severe
inflammatory process. An in-vitro study was conducted to evaluate the effect of Pet on the migration of human
peripheral blood monocytes-derived macrophages and its participation in the activation of the early inflammatory
response and cytokine expression.
Results: In the macrophage migration activation assay, Pet produced a similar effect to that induced by opsonized
zymosan (ZAS). Regarding the cytokine expression, an increase of IL-8, TNF-α (pro-inflammatory) and IL-10
(anti-inflammatory) was identified. In addition to the above results, the nuclear translocation of NF-kB pp65 was
also identified. These events are probably related to the inflammatory response identified in the histological
examination of intestine rat samples inoculated with Pet during a ligated loop assay.
Conclusion: The results showed that Pet participates as an immunostimulant molecule for macrophages, which
activates both their mobility and cytokine expression. These observations suggest that the toxin participates in the
inflammatory process that is observed during the host infection by EAEC Pet producing.
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Background
Enteroaggregative Escherichia coli (EAEC) is a pathogen
responsible of different cases of diarrhea, which include
acute, persistent, bloody, traveler’s diarrhea and also
diarrhea in HIV/AIDS patients [1]. Clinical and labora-
tory data suggest that the EAEC infection is associated
with the inflammation of intestinal mucosa [2]. In a
study on EAEC pathogenic mechanisms using an animal
model (gnotobiotic pigs) inoculated with different strains
isolated from infected patients, in different histological
sections were observed intestinal damage characterized
by shortening and rounding of intestinal microvilli from
enterocytes without apparent mononuclear cell infiltra-
tion in the mucosa [3]. Others researches observed in a
murine model that EAEC 042 (O44:H18) strain infection
induced hypersecretion of mucus, mild inflammatory
response with mononuclear infiltration and edema in the
lamina propria of the intestine [4]. Epidemiological studies
on EAEC infection in humans, showed the presence of
lactoferrin, IL-8 and IL-1β in feces of the infected people
[5–7]. In order to identify which components of the bac-
terium could be involved in the activation of the cytokine
expression, in different in-vitro assays using HT29 or T84
intestinal cell lines infected with the EAEC O42 strain,
was observed that the flagellin [8], the aggregative adher-
ence fimbriae (AAF) [9], as well as basolateral disruption
of epithelial cells [10] promoted the IL-8 release.
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Pet (Plasmid encoded toxin) is a protease which
belongs to the Serine Protease Autotransporters of
Enterobacteriaceae (SPATEs) initially described in the
EAEC O42 strain [11]. The in-vitro assays that have been
performed to understand the biological properties of Pet
show that it is a protease which induces cytotoxic and cyto-
pathic effects on different cultured cell lines. When the cell
damage was analyzed, it was identified that the alteration of
the cytoskeleton structure was an important factor in the
detachment of cells from the glass substratum [12]. In a cell
fractionation assay it was identified that the alterations
induced by Pet on the cytoskeleton were related to its cap-
acity to degrade the fodrin protein [13]. Studies of patients
with inflammatory bowel disease (IBD), Crohn’s disease and
cancer [14], the isolation of different SPATEs-producing-
E.coli strains was observed in more than a half of the sam-
ples. On the other hand, in the histological examination of
samples from patients with Crohn’s disease, the accumula-
tion of inflammatory cells, mainly macrophages M1, has
been observed, which determines the migration of cell sub-
populations, mainly TH1, as well as the expression of in-
flammatory mediators such as nitric oxide [15, 16].
The macrophages are a heterogeneous cell population
with a great plasticity that are able to stimulate primary im-
mune response through their PRRs groups such as the
TLRs, lectins and other receptors from these cells [17]. The
PAMPs-PRRs interaction activates the macrophages, which
increases their mobility and induces the expression of costi-
mulatory molecules as CD40 and ICAM that contributes to
the production of specific cytokines. All these events allow
an adequate immune response in the host [18].
Even if it was observed that the Pet activity participates
in the chronic inflammatory response during the EAEC
infection, the effect of the toxin in the innate immune
response has not been known so far. In order to explore
the Pet role in the innate immune response, it was ana-
lyzed if the toxin contributes to an increase of the migra-
tion and activation of human macrophages through the
synthesis of early and late response proteins such as IL-8,
TNF, IL-10 and the translocation of pp65 to NF-kB.
Methods
Bacterial strains
EAEC O42 (O44:H18) strain isolated from a child with
diarrhea in Lima, Peru [19]. Minimum clone of Pet
(pCFN1) generated by cloning pet from EAEC O42
strain into E. coli HB101 [11]. The EAEC O42 strain was
grown in agar and Luria broth (LB) without antibiotics;
the minimum clone was grown and maintained in the
same medium plus ampicillin (100 μg/mL).
Preparation and purification of Pet
Pet was obtained from the minimum clone (E. coli HB101
pCFN1) according to the method previously described [13].
Briefly, the strain HB101 (pCEFN1) was inoculated in tubes
with 3 ml of LB plus ampicillin (Amp) and incubated for
6 h at 37 °C with constant stirring (Newbrownskii) at
200 rpm. Then, 1 ml of the first culture was added into 1 L
of fresh LB +Amp medium and the incubation was contin-
ued for 18 h at 37 °C with constant stirring (200 rpm). The
culture was centrifuged (Sorvall RC5) at 10,000 g at 4 °C
for 30 min. The supernatant was precipitated with ammo-
nium sulfate at 60 % of saturation (361 g of salt/L) and was
kept at rest overnight at 4 °C. The precipitated proteins
were concentrated by centrifugation (Sorvall RC5) at
10,000 g at 4 °C for 30 min. The protein pellet was sus-
pended in sodium phosphate buffer (0.07 M, pH = 8.2)
and dialyzed during 2 days with buffer changes every
12 h. Afterwards, proteins were dialyzed in 0.05 M
Tris-HCl plus 0.01 M EDTA (pH = 8.0). The protein
precipitate was subjected to an anion exchange chroma-
tography (Q-sepharose. Pharmacia, USA), using buffer A
(0.05 M Tris-HCl plus 0.01 M EDTA, pH = 8.0) and buffer
B (0.5 M NaCl). The first peak of the Q-Sepharose
chromatography was subjected to another separation
by using the cation exchanger resin Mono S HR 5/5
(Pharmacia, USA) under moderate pressure and rapid
flow (FPLC) using the buffers A and B. The elution profile
was analyzed at 280 nm. The protein concentration was
quantified using a microplate by the Bradford method;
bovine serum albumin was used as standard. Colorful re-
action was measured in a spectrophotometer [20] at
595 nm (Bio-Rad Protein Assay, cat number 500–0001).
The purified protein was stored at−20 °C until its use.
LPS elimination (endotoxin) by polymyxin-B agarose gel
The contained endotoxin in Pet preparations was eliminated
using polymyxin-B agarose gel (Detoxi Gel, Pierce), accord-
ing to the recommended instructions by the supplier. Briefly,
aliquots of 0.5 mL polymyxin-B in agarose were dropped on
the polypre columns of 0.5 mL (Pierce). The column was
equilibrated by washing; five volumes phosphate buffer
solution (PBS) and ten volumes 1 % sodium deoxycholate.
A 250 μL aliquot of Pet (300 μg/mL) was placed on the
column and was kept at room temperature for 60 min. The
column was eluted with PBS and from this were collected
250 μL of toxin (Pet). Protein concentration was determined
by the Bradford method and its purity was analyzed by poly-
acrylamide gel electrophoresis (SDS-PAGE).
Endotoxin activity
Protein free of endotoxin was evaluated by the Limulus
Amebocyte Lysate (LAL) assay (Cat. N-289–06, LONZA),
following the manufacturer's recommendations. Briefly,
100 μL of Pet protein fraction was mixed with 100 μL of
LAL and incubated for 60 min at 37 °C; the assay was per-
formed in duplicate. The endotoxin concentration was
established by comparing the data obtained in the negative
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and positive endotoxin controls. Values of 0.125 EU/mL
or less were considered suitable for the usage of Pet in
assays of toxin activity.
Ligated loop model in rats
Sprague Dawley Rats (n = 4) weighing between 100 and
150 g, both sexes, were used for a ligated loop model.
The experimental animals were obtained from CICUAL
(CINVESTAV-IPN Animal Ethics Committee) and the
assays were carried out according to the Official Mexican
Standard NOM-062-ZOO-1999 (Norma Oficial Mexicana),
which specifies the lawful techniques for the production,
care and use of laboratory animals. In preparation of intes-
tinal loops, the animals first received the anesthetics Xyla-
zine (6.5 mg/kg) and Ketamine (34.5 mg/kg). Once the rats
fell asleep, laparotomy and exposure of the small intestine
were performed. Three segments of intestine were prepared
of approximately 10 cm of length with an intermediate of
3 cm between each loop. To form the loops, a sterile surgi-
cal suture (# 0) was used. Each segment was inoculated
with 1000 μL of 1.5 × 108 CFU of Pet producing-E coli O42
strain. In alternative assays, the segments of terminal ileum
were inoculated with 100 μg of purified Pet; PBS was used
as negative test control. After inoculation of intestine seg-
ments, they were taken back to the abdominal cavity, the
incision was stitched with the same surgical suture and the
animals were left in the presence of sterile water for its
consumption ad libitum. Twelve hours after having done
the described treatment, the animals (prior anesthesia with
Xylazine 6.5 mg/kg) were sacrificed by cervical dislocation
and the ileum segments were dissected. The intestinal
content was removed and afterwards, segments of appr-
oximately 1.0 cm were obtained for histological analysis.
The intestinal samples were fixed with buffered formalin
(pH 7.3, 10 %) and were embedded in paraffin. Serial
sections of approximately 5 μm thick were cut and
fixed on the glass slides. The preparations were stained
with hematoxylin and eosin according to the proce-
dures used by the Biological Stain Commission.
Culture and preparation of human peripheral blood-derived
macrophages
Mononuclear cells were obtained from the leukocyte
concentrates bags (Buffycoat) from samples of four do-
nors (according to the approval guidelines by Bioethics
Committee) from the blood bank of Hospital Infantil
de México Federico Gómez. The mononuclear cells
fraction was obtained by gradient centrifugation Lym-
phopred™ (Nycomed AS, Oslo, Norway). Once sepa-
rated, it was washed three times with physiological
saline solution and obtained monocytes were purified
by the negative selection method using a mixture of
antibodies anti-CD3, CD7, CD19, CD45RA, CD56 and
anti-IgE (MiltenyiBiotec, BergischGladbach, Germany)
according to the manufacturer’s indications. The purity
of monocytes was evaluated by flow cytometric analysis
using anti-CD14 conjugated to FITC (Pharmingen, San
Diego, CA, USA). Purified monocytes (3 × 105 mono-
cytes/mL) were differentiated to macrophages through
culturing the cells for 7 days in low attachment plates
of 24 wells (Costar, Corning, NY, USA) in RPMI-1640
medium supplemented with 10 % of fetal bovine serum
(FBS) (Gibco, Invitrogen USA).
Chemotaxis
The Pet chemotactic effect was analyzed in Boyden cham-
ber of one well with double filter (Neuroprobe Inc, USA).
The chamber was prepared by placing one filter of nitrocel-
lulose with a diameter of 0.5 μm (Nucleopore) in the upper
compartment and a cellulose nitrate filter with 8 μm on the
bottom which was used as a receptor of migrated cells. A
suspension of approximately 8 × 105 mononuclear cells in
0.5 mL of Hanks’ solution were placed in the upper cham-
ber; in the lower chamber, 1.7 mL of Hanks’ solution with
5, 10 or 20 μg/mL of Pet were applied. Opsonized zymosan
(ZAS) and Hanks’ solution with BSA (0.2 %) were used as
the positive and negative controls, respectively. The cham-
bers were incubated up to 90 min at 37 °C in atmosphere
of 5 % CO2. After the chambers had been emptied, the
filters were removed and the cells adhered to the bottom of
the lower chamber filter were fixed with 80 % ethanol dur-
ing 15 min at room temperature. Then, cells were stained
with Harris hematoxylin and the membranes were hydrated
first with ethanol-Xylene (1:1) and later with Xylene
(100 %). The membranes were placed over the slides and
fixed with balsam resin from Canada. The cell count was
performed by three different readers in an optical micro-
scope (400X) and the count was analyzed in 5 different
fields. The chemotaxis was expressed as the percentage of
migrating cells.
Cytokine expression
The previously obtained macrophages were challenged with
different Pet concentrations (5, 10 and 20 μg/ml) for 6 and
24 h. The concentration of pro-inflammatory cytokines
(IL-8, TNF-α) and anti-inflammatory (IL-10) from the
supernatant of each sample were measured by ELISA
with capture and antibodies detection (BD Pharmingen,
San Diego, CA, USA), according to the manufacturer’s
indications. Briefly, the ELISA plates (Costar) were
treated with 100 μL of capture antibody of each cytokine
diluted (1:250) in carbonate buffer pH 9.2. They were in-
cubated overnight at 4 °C, then, the antibody was elimi-
nated and 100 μL of blocking solution (10 % FBS in PBS)
was added to each well and further incubated for 1 h at
room temperature. At the end of the incubation, the plates
were washed 3 times with 300 μL of PBS/tween at 0.05 %,
the cytokines controls and each one of the samples were
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added, and they were incubated for 2 h at ambient
temperature. Each well was washed five times (0.05 %
PBS/tween) and in order to observe the reaction, with de-
tection antibody (1:250) and a conjugate of streptavidin-
horseradish peroxidase (1:250) were added to each well;
the plates were incubated for 1 h at room temperature.
The wells were washed 7 times (0.05 % PBS/tween) and
100 μL of TMB substrate (Reagent Set BD Pharmingen,
San Diego, CA, USA) was added and incubated for
30 min more (protected from the light). The reaction was
stopped with 50 μL of 2 N H2SO4 solution and finally the
quantification was performed in an ELISA reader at
450 nm (Dynatech, MR580). The concentration of differ-
ent cytokines was determined using a standard curve in
pg/mL. Macrophages that were stimulated with both poly-
myxin B sulphate (Sigma, St Louis CA; 10 μg/mL) and
LPS 0111:B4 (Sigma Chemical Co., St. Louis, MO, USA;
100 ng/mL) were used as controls.
NF-kB (pp65) translocation
The location and translocation of NF-kB protein in hu-
man macrophages adhered to glass slides, were analyzed
using the Cellomics NF-kB kit (Thermoscientific) by an
immunofluorescence assay following the manufacturer's
instructions. The macrophages samples were treated
separately with RPMI-1640 (10 % FBS), Pet (10 μg/mL)
and 100 ng/mL LPS of E. coli 0111:B4 (Sigma Chemical
Co., St. Louis, MO, USA). The preparations were incubated
for 30 min at 37 °C in atmosphere of 5 % CO2. These were
washed two times with PBS, permeabilized with Triton X-
100 (0.1 %) and fixed with paraformaldehyde (4 %). The cells
were blocked with 2 % BSA and normal horse serum (5 %)
in Dulbecco-PBS solution for 30 min. Afterwards, they were
incubated for another hour with NF-kB primary antibody
(rabbit monoclonal anti-NF-kBpp65, Thermoscientific). The
preparation was washed and incubated for another hour
with staining antibody 1:2000 and secondary antibody 1:500
(Hoescht Dye and Dylight 488 Goat anti-rabbit). The
fluorescence of macrophages to the different stimuli was
observed using an epi-fluorescence Zeiss Axioskop 2
microscope, Zeiss Axiocam (Zeiss AG, Oberkochen, DE).
The percentage of positive cells to pp65 was performed by
counting 100 cells per field in four separated experiments.
Statistical analysis
The results are reported as mean ± SD, of each experiment
in a total of four donors in duplicate samples. Differences
between the levels of cytokine were assessed using Wilcoxon
test. Differences were considered significant if P was < 0.05.
Results
Pet purification
The Pet protein was obtained from the culture super-
natant and identified between the 34 to 39 fractions of the
cationic exchange column (Mono S HR 5/5 Pharmacia,
USA) (Fig. 1a). The analysis of separated fractions (SDS-
PAGE) showed a 104 kDa band with more than 90 % of
purity. The Pet identity was confirmed by a Western-Blot
test using specific antibodies (Fig. 1b).
Pet effect on intestinal epithelium
The histological analysis of tissue samples obtained from
the intestinal ligated loops of rats, showed the presence
of hemorrhage, necrosis, ulceration and fibrino purulent
exudates in the intestinal epithelium samples in both,
the inoculated with the live bacteria (Fig. 2a) and in
those challenged with the purified Pet fraction (Fig. 2b).
The preparations of the inoculated loop only with PBS
did not showed alterations in the epithelium (Fig. 2c).
Pet chemoattractant effect on macrophage
The different Pet concentrations (5 to 20 μg/mL) that
were used in the chemotaxis assay activated the macro-
phage migration. The observed chemotactic effect was
similar to the one which was induced by ZAS. It was
also identified that the Pet effect depends on the con-
centration, the maximum migration was determinate to
20 μg/mL after 90 min of incubation (Table 1).
Cytokines produced by macrophages
The MDM (human peripheral blood monocytes-derived
macrophages) treated with different Pet concentrations (5
to 20 μg/mL) induced the production of IL-8 from 6 and
to 24 h of incubation. The maximum concentration of IL-
8 was identified at 6 h in macrophages challenged with
10 μg/ml of toxin (Fig. 3a). The results showed one loga-
rithmic increase when comparing the levels obtained in
the cells without treatment, but with the similar values to
the observed ones in the stimulated MDM with 0.1 μg/ml
of LPS 0111:B4. The levels of IL-8 decreased at 24 h with
the concentrations of 5 and 10 μg/ml, however, these cyto-
kine remained high in the cells treated with 20 μg/ml of
Pet (Fig. 3a). The effect of low concentrations of Pet
(0.001 to 1 μg/ml) on the MDM was similar to the one
obtained in the cells without treatment (data not shown).
In order to exclude that the activation of macrophages
were due to an effect of residual LPS in Pet, both the toxin
and the LPS 0111:B4 were treated with Polymyxin-B before
the challenge. The results of the test showed a decrease of
almost 41 and 25 % in IL-8 expression at 6 and 24 h in the
MDM challenged with LPS treated with Polymyxin-B. The
same test with Pet (20 μg/mL) treated with Polymyxin-B
did not show changes in the IL-8 expression levels of the
MDM treated with Pet alone (Fig. 3a). In this test, it was
also identified that Pet activated the early expression of
TNF-α (Fig. 3b) and the production of IL-10 with highest
levels at 6 h, but with a decrease of more than 50 % after
24 h (Fig. 3c). On the other hand, analyzing the expression
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of IL-1β, IL-6 and IL-12 cytokines, it was found that Pet
stimulates their expression using the concentrations from 5
to 20 μg/ml (data not shown).
NF-kB (pp65) activation
The macrophages challenged with Pet also induced the
activation and translocation of the NF-kB pp65 protein.
This event was observed in more than 60 % of the cells
after 30 min incubation. The same test in MDM stimu-
lated with the LPS 0111:B4 showed activation in more
than 90 % of cells. However, in non-treated MDM, the
pp65 activation was observed in approximately 20 % of
the cells (Fig. 4a, b).
Discussion
The diarrhea caused by EAEC is the result of a complex
interaction between the pathogen and the host. In this
regard, it is interesting observed that in different clinical
diseases induced by the enteroaggregative E. coli group,
constantly is noted the activation of an inflammatory re-
sponse [1, 2, 21–23], may be induced by LPS, fimbriae
(AAF) or flagellin [8–10, 24]. On the other hand, the
isolation of different E.coli strains that secreted SPATEs,
have been observed in patients with IBD, cancer and
Crohn’s disease [14]. In addition, in biopsies from patients
with Crohn’s disease it has been identified inflammatory
cells mainly macrophage subpopulations M1 [15, 16]. An
interesting observation during a diarrhea outbreak associ-
ated with the EAEC infection, was the identification in the
intestine autopsy of a child who passed away, the presence
of inflammatory infiltration of lymphocytes and plasma
cells, as well as the necrosis of the glandular epithelium
and alterations associated with a clinical picture of entero-
colitis (personal communication from Meyer-Gómez R.
H. and Cravioto A.). In Pet toxin have been identified dif-
ferent biological properties [12, 13], some of them consid-
ered as the possibly cause of the intestinal alterations and
the diarrhea caused by EAEC strains [11]. In this work, it
was identified that the live Pet-producing bacteria as well
as purified toxin fractions caused epithelium damage
(Fig. 2a, b), alterations similar to those described in the in-
testine autopsy of the child previously referred.
Directed cell migration (chemotaxis) of neutrophils,
monocytes and macrophages; i.e. inflammatory mediator
A
B
Fig. 1 Purification of Pet protein by FPLC. Pet protein was purified from supernatant of the minimal clone HB101(pCEFN1).a Culture supernatant
ammonium sulfateprecipitated was passed through a Q-Sepharose and FPLC columns. b The toxin specificity was analyzed by Western blot with
anti-pet antibody (1:500) and the reaction visualized with rabbit anti-IgG antibody conjugated with alkaline phosphatase (1:5000). The reaction
was evidenced adding BCIP/NBT. Lines: MW markers; 1 Pet toxin; 2 Entamoeba histolytica HMI-IMSS antigen
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cells, is an early step of the host innate immune response
[25]. Some synthetic compounds, others that form a
structural part of microorganisms (LPS, lipoteichoic
acids, mycolic acids, glycolipids, lipoarabinomanana,
polynucleotides, glycosylphosphatidylinositol, bacterial
DNA, lipoproteins, flagellin), and cellular factors as
IL-8, C5a of complement, formylated peptides (FMLP)
and leukotrienes, possess adjuvant and activation ef-
fects of the innate immune system [24, 26–28]. Ulises
et al. [29], mentioned that Pet is a chemoattractant
factor of mononuclear cells (MN), the results of our
study show that Pet activates chemotaxis of MDM,
similar effect was obtained when the same cells are
treated with ZAS, i.e. a compound of known chemotactic
activity. The activation of cellular factors is induced as a
protective mechanism against infection and colonization
by microorganisms in epithelia [30]. If a secreted molecule
by bacteria induces the migration of inflammatory cells, it
could be expected as a suicide action of microorganism.
However, the data obtained from studies using a mouse
model infected with S. Typhimurium [31], shows that the
intestinal inflammation induced by the bacteria infection
alters the composition of the microbiota and suppresses
its growth. So, it suggested that the inflammation is a posi-
tive factor for the survival and expansion of Salmonella.
An possible explanation as the bacteria can survive in
unfavorable conditions, as is the case of an inflammatory
process have been observed in Serratia marcescens, this
bacteria secrete a protease of 56 kDa which has the
property to inhibit the chemotactic function of C5a [32],
similar observations were described in E. coli 0157:H7,
this bacteria produce the metallo protease mucinase
STcE type, which inhibits leukocyte and polymorpho-
nuclear cells migration by mechanisms that involve par-
ticipation of mucin-homologous glycoproteins [33].
EAEC besides Pet also secreted Pic protein, which also
is member of the SPATEs family with mucinase activity
[34] and capacity of decrease the chemotaxis and trans-
migration of leukocytes [35]. This feature in which two
molecules expressed by the same bacteria with antagon-
istic effects, confirms the ability of some microorganisms
to stay in the host using different properties that can be
called of survival.
In the model of EAEC pathogenesis there are multiple
factors which influence the inflammation scale [36, 37].
The Pet participation in the activation of the immune re-
sponse only has been associated in chronic processes, but




Fig. 2 Histological Study of fractions obtained from rat ileal loops. Rat
ileal loops inoculated with: a live O42EAEC bacteria (1.5 × 108 UFC/mL);
b 100 μg of purified Pet toxin and c PBS. The intestine preparations were
Hematoxilin-Eosin stained and observed in light microscope
(400X). Presence of hemorrhage (arrow), necrosis (arrow), ulceration
and fibrinopurulent exudates (arrow) of the intestinal epithelium a and
b. Non histological changes were observed in c
Table 1 Activation of human macrophages migration induced
by Pet Protein in a Boyden chamber assay
Treatment Cells number × fieldsa Macrophages
migration
percentage
Hank’s solution BSA (0.2 %) 5 ± 2.5 16
ZAS 30 ± 3.4 100
Pet 5 μg/ml 10 ± 2.2 33
Pet 10 μg/ml 15 ± 5.1 50
Pet 20 μg/ml 22 ± 4.3 73
Values are mean ± SD
aCells x fields refers the migrated cells counted in five randomly selected fields
what were observed under a microscope set at 400 X magnification. The date
of percentage presented are compared with the 30 cells observed with the
stimulus treatment with ZAS (Positive control)
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Fig. 3 Cytokines production of MDM stimulated with Pet toxin from EAEC. Supernatants of MDM stimulated with Pet (1 to 20 μg/ml) were
analyzed by ELISA test to determine the cytokines expression. a IL-8, b TNF-α and c IL-10. The MDM cells were treated with E. coli. 0111:B4 LPS
(0.1 μg/ml); Polymyxin B (PMB), LPS and Polymyxin B (LPS/PMB), Pet (20 μg/ml) and Polymyxin B (Pet20/PMB), and untreated cells (s/e). The cytokine
concentrations weredeterminedat 6(□) and 24 h (■) of stimulation. The results are the means ± of the standard deviation representative of four
independent experiments. Significant P < 0.05 (*), as compared between 6 and 24 h of stimulation
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the innate immune response. The results of our study
propose Pet as a molecule which activates the production
of pro-inflammatory cytokine IL-8 and TNF-α, both cyto-
kines with important biologic effects since they participate
in the regulation of the early inflammatory response and
the activation of macrophages [38, 39].
Cytokine IL-10 with anti-inflammatory and immunosup-
pressive activity, as well as control of macrophage effector
functions [40], was also detected in this work. The IL-10
production induced by Pet was identified in its highest
levels at 6 h; although, this effect was not expected because
it’s synthesis and kinetics is a delayed event. Also it was ob-
served that the IL-10 values decreased almost 50 % after
24 h, this suggest that the early synthesis of IL-10 induced
by Pet, could be related to a transient immunosuppression
mechanism which allows to E. coli to survive in the intes-
tine in the stage of adaptation to new niches. This transient
effect has been described in other pathogens, in which it
has been proposed that IL-10 mediated the negative
regulation of the innate immune response, although
B
A
Fig. 4 Immunofluorescence analysis of NF-kB activation. a Human macrophages were stimulated during 30 min with Pet (10 μg/ml) or LPS (Positive
control) and non-stimulated. The nuclear translocation is determined (arrows) by the blue fluorescence (Hoechst staining) and the NF-kB p65 subunit
(arrows) by its green fluorescence (Dylight 488). b Percentage of nucleic positive cells to p65. The results are representative of three
independent experiments
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this represents a risk for the host [41, 42]. The Toll-like
receptors (TLRs) expressed in different cells including
macrophages activate the extracellular signaling pathways
after having recognized the PAMPs-type molecules; i.e. an
event that leads to the release of NF-kB and their trans-
location to the nucleus. In the study, it was observed that
Pet significantly induced the translocation of pp65 after
30 min of stimulation. Different reports showed that dur-
ing the activation of the transcription factor NF-kB in the
response to various stimuli by pathogens and bacterial
molecules, its translocation from the cytoplasm to the nu-
cleus is an event where the signaling pathway participates
for the synthesis of several cytokines [42]. In their study,
Benitez et al. [43], indicated the early expression of mRNA
inflammatory mediators (IL-1, TNF-α, MIF, antagonist re-
ceptor of IL-1 [LTRa]) in the line of murine macrophages
J774 activated by the Pet protein, through signaling path-
ways iKKαβ/NF-kB and MAP kinases. In epithelial cells
derived from the intestines, has been reported the partici-
pation of the cytokeratin 8 (CK8) as the Pet receptor [44].
However, until now in the immune cells, the receptors
activated by Pet are not clearly defined, in this study it
was evaluated as one possibility the PAMP-type mol-
ecule through the TLR2 and TLR4 receptor using
transfected HEk-293 cells (human embryonic kidney
cells), however, the results showed that Pet is not a
PAMP-type molecule (data not shown).
Conclusion
In summary the results provide the fundamental findings
in order to propose that in-vitro activation of the innate
immune system induced by Pet involves the recruitment
of human macrophages, the synthesis of pro-inflammatory
cytokines and the NF-kB activation. These suggest the
possible association of the Pet protein to polarization
immune responses of M1 macrophages and also TH1
immune responses.
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